Abstract
BackgroundFerritin plays a central role in the intracellular iron metabolism; the molecule is a nanocage of 24 subunits of the heavy and light types. The heavy subunit (FHC) is provided of a ferroxidase activity and thus performs the key transformation of iron in a non-toxic form. Recently, it has been shown that FHC is also involved in additional not iron-related critical pathways including, among the others, p53 regulation, modulation of oncomiRNAs expression and chemokine signalling. Epithelial to mesenchymal transition (EMT) is a cellular mechanism by which the cell acquires a fibroblast-like phenotype along with a decreased adhesion and augmented motility. In this work we have focused our attention on the role of the FHC on EMT induction in the human cell lines MCF-7 and H460 to elucidate the underlying molecular mechanisms.MethodsTargeted silencing of the FHC was performed by lentiviral-driven shRNA strategy. Reconstitution of the FHC gene product was obtained by full length FHC cDNA transfection with Lipofectamine 2000. MTT and cell count assays were used to evaluate cell viability and proliferation; cell migration capability was assayed by the wound-healing assay and transwell strategy. Quantification of the CXCR4 surface expression was performed by flow cytometry.ResultsExperimental data indicated that FHC-silenced MCF-7 and H460 cells (MCF-7shFHC, H460shFHC) acquire a mesenchymal phenotype, accompanied by a significant enhancement of their migratory and proliferative capacity. This shift is coupled to an increase in ROS production and by an activation of the CXCR4/CXCL12 signalling pathway. We present experimental data indicating that the cytosolic increase in ROS levels is responsible for the enhanced proliferation of FHC-silenced cells, while the higher migration rate is attributable to a dysregulation of the CXCR4/CXCL12 axis.ConclusionsOur findings indicate that induction of EMT, increased migration and survival depend, in MCF-7 and H460 cells, on the release of FHC control on two pathways, namely the iron/ROS metabolism and CXCR4/CXCL12 axis. Besides constituting a further confirmation of the multifunctional nature of FHC, this data also suggest that the analysis of FHC amount/function might be an important additional tool to predict tumor aggressiveness.
Highlights
Ferritin plays a central role in the intracellular iron metabolism; the molecule is a nanocage of 24 subunits of the heavy and light types
Silencing of H ferritin triggers Epithelial to mesenchymal transition (EMT) in MCF-7 cells We previously demonstrated that Ferritin heavy chain (FHC) intracellular amounts may regulate the expression of a number of miRNAs and EMT-related genes in different cell types [17, 19, 34]
Since C-X-C chemokine receptor type 4 (CXCR4) has been shown to activate mTOR pathway via AKT [22] we evaluated the levels of p-S6 ribosomal kinase (S6 K), the downstream effector of mTOR [47,48,49]. pAKT activation in MCF-7shFHC cells corresponded to increased phosphorylation of S6 K, which is not inhibited by AMD3100 (Fig. 6 Panel F)
Summary
Ferritin plays a central role in the intracellular iron metabolism; the molecule is a nanocage of 24 subunits of the heavy and light types. The activation of the EMT process leads to cytoskeleton re-organization, loss of cell-cell adhesion molecules, modification of cellular polarization, de novo expression of mesenchymal proteins and acquisition of stemness properties [1, 2]. The enzymatic activity held by FHC makes it a key molecule in the control of the intracellular free iron and, as a consequence, of ROS production; it has been hypothesized, and demonstrated in given cell types, a role for FHC in EMT induction [10]
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have